abrdn Healthcare Opportunities Fund - SHS (THQ)

Historical Holders from Q3 2014 to Q3 2025

Symbol
THQ on NYSE
Type / Class
Equity / SHS
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
7,701,858
Holdings value
$133,246,186
% of all portfolios
0%
Number of holders
105
Number of buys
58
Number of sells
-40
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of abrdn Healthcare Opportunities Fund - SHS (THQ)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 7,701,858 $133,246,186 -$14,499,777 $17.29 105
2025 Q2 8,439,330 $155,179,325 -$1,024,056 $18.39 98
2025 Q1 8,437,703 $174,135,760 +$7,926,744 $20.64 93
2024 Q4 8,229,276 $155,613,361 -$948,381 $18.87 105
2024 Q3 8,258,510 $182,047,091 -$5,615,679 $22.08 103
2024 Q2 8,553,718 $174,176,399 -$18,483,358 $20.38 96
2024 Q1 9,328,157 $187,258,445 -$24,553,132 $20.1 93
2023 Q4 10,647,001 $192,823,846 +$25,661,448 $18.11 98
2023 Q3 9,176,095 $155,810,245 +$8,608,859 $16.98 91
2023 Q2 8,643,030 $164,816,590 +$2,805,836 $19.07 78
2023 Q1 8,500,488 $159,488,973 -$2,387,400 $18.76 89
2022 Q4 8,602,876 $170,419,448 +$6,068,470 $19.81 85
2022 Q3 8,297,744 $150,388,503 +$4,669,533 $18.12 78
2022 Q2 8,039,552 $160,310,094 -$1,615,464 $19.94 83
2022 Q1 8,105,159 $180,351,380 +$1,840,752 $22.26 92
2021 Q4 7,989,562 $204,858,448 -$3,961,463 $25.64 90
2021 Q3 8,098,781 $183,472,855 +$3,443,833 $22.65 79
2021 Q2 7,942,792 $183,505,085 -$3,330,241 $23.1 76
2021 Q1 8,001,015 $173,847,350 -$4,173,848 $21.73 71
2020 Q4 8,190,211 $166,803,095 -$1,905,417 $20.38 66
2020 Q3 8,273,826 $149,584,523 -$2,083,012 $18.09 64
2020 Q2 8,354,717 $148,603,450 +$8,701,587 $17.8 67
2020 Q1 7,715,908 $118,479,128 -$17,515,655 $15.36 77
2019 Q4 8,561,403 $163,258,000 +$4,881,050 $19.07 65
2019 Q3 7,999,035 $139,611,111 +$149,367 $17.46 58
2019 Q2 7,976,471 $142,103,237 -$6,448,765 $17.82 60
2019 Q1 8,651,600 $152,356,167 -$4,326,753 $17.62 64
2018 Q4 8,898,907 $149,301,873 -$1,325,860 $16.78 59
2018 Q3 8,919,595 $167,161,849 +$7,642,059 $18.74 69
2018 Q2 8,527,975 $146,056,633 +$7,778,558 $17.04 70
2018 Q1 8,060,492 $132,954,284 +$7,966,705 $16.48 63
2017 Q4 7,558,349 $132,423,236 -$907,100 $17.52 66
2017 Q3 7,584,736 $140,854,000 +$8,328,017 $18.57 57
2017 Q2 7,138,272 $130,915,000 +$7,255,452 $18.34 52
2017 Q1 6,748,998 $117,373,000 -$4,969,603 $17.4 53
2016 Q4 7,038,505 $110,139,000 +$7,665,887 $15.52 54
2016 Q3 6,563,640 $114,732,000 +$8,362,450 $17.48 48
2016 Q2 6,198,267 $103,113,497 +$3,860,783 $16.63 52
2016 Q1 5,416,162 $86,208,345 -$2,414,674 $15.91 40
2015 Q4 6,044,798 $105,097,000 +$13,570,935 $17.39 45
2015 Q3 5,253,133 $85,669,000 +$9,733,306 $16.3 41
2015 Q2 4,634,759 $91,830,081 +$14,358,838 $19.83 30
2015 Q1 3,909,164 $80,036,676 +$19,267,010 $20.58 26
2014 Q4 2,955,026 $59,241,115 +$34,789,198 $20.05 19
2014 Q3 1,128,902 $21,280,000 +$21,280,000 $18.85 14